Clinical Trial Update: Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) [NA]

View source ↗

Summary

Pfizer completed an extension trial of PF-05280586 for rheumatoid arthritis patients who had previously participated in other PF-05280586 trials; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PF-05280586

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED | Results posted: 2017-06-08